Literature DB >> 31594748

Neuroprosthetics 2.0.

Simon Hazubski1, Surjo R Soekadar2, Harald Hoppe3, Andreas Otte4.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31594748      PMCID: PMC6838431          DOI: 10.1016/j.ebiom.2019.09.036

Source DB:  PubMed          Journal:  EBioMedicine        ISSN: 2352-3964            Impact factor:   8.143


× No keyword cloud information.
It was a true delight to read the intriguing Editorial "Human-robotic interfaces to shape the future of prosthetics” in one of the recent EBioMedicine issues, which is more than timely [1]. While this editorial primarily addresses the assistive use of neuroprosthetics, there is another aspect to this technology that is now emerging as a “hot topic” in the field: application of neuroprosthetics to purposefully induce neuroplasticity that triggers neural recovery [2,3]. Here, it is even truer that success of this application depends on considering the real-life wishes of patients, as the desired (use-dependent) neuroplasticity critically depends on adoption of the technology into the user's day-to-day activities. Moreover, interests of those using this technology (such as data security, safety, accountability) have to be protected and related neuroethical issues discussed [4]. As outlined in the editorial, current neuroprosthetic technologies develop rapidly, but some of them are invasive or discomforting for the user. Therefore, future prosthetic devices should be as intelligent but also as simple as possible. For this, new concepts for controlling the prosthetics are essentially needed, e.g. by inclusion of augmented reality (AR) into current intention detection methods (e.g., electromyography, electrooculography, or electroencephalography) as an add-on to the concept [5]. Even more, stand-alone (non-contact) concepts of AR glasses controlling the prosthesis may help to simplify usability of modern prosthetics. The invitation of EBioMedicine to submit biomedical and bioengineering research on smart neuroprosthetics is thus more than welcomed!

Authors' contributions

All authors contributed equally to the manuscript.

Declaration of Competing Interest

Authors declare no conflicts of interest to be reported.
  4 in total

1.  Help, hope, and hype: Ethical dimensions of neuroprosthetics.

Authors:  Jens Clausen; Eberhard Fetz; John Donoghue; Junichi Ushiba; Ulrike Spörhase; Jennifer Chandler; Niels Birbaumer; Surjo R Soekadar
Journal:  Science       Date:  2017-06-30       Impact factor: 47.728

2.  Brain-machine interfaces in neurorehabilitation of stroke.

Authors:  Surjo R Soekadar; Niels Birbaumer; Marc W Slutzky; Leonardo G Cohen
Journal:  Neurobiol Dis       Date:  2014-12-07       Impact factor: 5.996

3.  Targeted neurotechnology restores walking in humans with spinal cord injury.

Authors:  Fabien B Wagner; Jean-Baptiste Mignardot; Camille G Le Goff-Mignardot; Karen Minassian; Jocelyne Bloch; Grégoire Courtine; Robin Demesmaeker; Salif Komi; Marco Capogrosso; Andreas Rowald; Ismael Seáñez; Miroslav Caban; Elvira Pirondini; Molywan Vat; Laura A McCracken; Roman Heimgartner; Isabelle Fodor; Anne Watrin; Perrine Seguin; Edoardo Paoles; Katrien Van Den Keybus; Grégoire Eberle; Brigitte Schurch; Etienne Pralong; Fabio Becce; John Prior; Nicholas Buse; Rik Buschman; Esra Neufeld; Niels Kuster; Stefano Carda; Joachim von Zitzewitz; Vincent Delattre; Tim Denison; Hendrik Lambert
Journal:  Nature       Date:  2018-10-31       Impact factor: 49.962

4.  Human-robotic interfaces to shape the future of prosthetics.

Authors: 
Journal:  EBioMedicine       Date:  2019-08       Impact factor: 8.143

  4 in total
  1 in total

1.  Tapered fibertrodes for optoelectrical neural interfacing in small brain volumes with reduced artefacts.

Authors:  Barbara Spagnolo; Antonio Balena; Rui T Peixoto; Marco Pisanello; Leonardo Sileo; Marco Bianco; Alessandro Rizzo; Filippo Pisano; Antonio Qualtieri; Dario Domenico Lofrumento; Francesco De Nuccio; John A Assad; Bernardo L Sabatini; Massimo De Vittorio; Ferruccio Pisanello
Journal:  Nat Mater       Date:  2022-06-06       Impact factor: 47.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.